-
Ex-Thai MP shoots dead local official over money row
-
US, South Korea to drill for new threats from North
-
July was Spain's hottest month on record: weather agency
-
Record July heat in regions home to 900 mn people: AFP analysis
-
Embattled Infantino target of letter from three confederations
-
Eighth day of wildfires in Indonesian national park
-
Chinese AI drives price competition among US labs
-
One woman confirmed dead in western Canada wildfire
-
Indian students step up exam protests in Jharkhand
-
Energy transition threatens to wipe Dutch village from map
-
Stopped broadcast, layoffs: Hungary media eyes post-Orban renewal
-
Self-taught Turkish 'linguist' keeps dead language alive
-
Typhoon Dolphin weakens but disrupts travel in east China
-
Asian stocks track Wall St higher after US job losses ease rate fears
-
Pakistan brickmakers scorched by sun above and fire below
-
Western Europe experienced hottest June-July on record: EU monitor
-
Ithaca bets on hometown hero Odysseus for tourism boom
-
Shelton sweeps Fonseca to reach Montreal quarter-final
-
Five things to know about Zambia ahead of the presidential vote
-
Who are the main contenders in Zambia's presidential vote?
-
Zambia vote to test Hichilema's economic record
-
Rybakina survives scare as Gauff, Osaka race into Toronto quarters
-
Meta will soon face another high-stakes trial in US
-
Thirty years on, a trial finally opens in Tupac Shakur's killing
-
Syria says reached deal with Moscow on fate of Russian bases
-
Shelton sweeps Fonseca to reach another Montreal quarter-final
-
Netanyahu rejects Gaza plan in new break from Trump
-
ABL Ascend Advanced Therapies Names Suman Subramanian as Chief Business Officer
-
Brennan captures Wyndham crown for second PGA win
-
Kurdish PKK criticises Turkey bill on fate of its fighters
-
Rybakina, Gauff advance to Toronto quarter-finals
-
Clay-courter Merida on hardcourt learning curve in Montreal
-
Rahm three-peats as LIV Golf season champ while Niemann wins at New York
-
NBA champion player and historic coach Nelson dead at 86
-
Vollering wins Tour de France Femmes after war of nerves
-
BMW iX3 Flow Edition brings animated bodywork closer to reality
-
BMW’s next chapter accelerates with New Class rollout
-
Arteta backs Guimaraes to 'ignite something different' at Arsenal
-
Five dead in new Russia, Ukraine strikes
-
Como sign England defender Chalobah from Chelsea
-
PSG sign France full-back Digne from Villa
-
Demi Vollering wins Tour de France Femmes
-
Sinner withdraws from Cincinnati Open with knee injury
-
Iraola's first Anfield match as Liverpool manager ends in Monaco defeat
-
Fernandez's 'perfect' race earns him British MotoGP Grand Prix win
-
Bodies hanging from bridge revive violence in once-calm town in Mexico
-
Iran Guards say won't reopen Hormuz without US meeting Tehran's demands
-
Lionel Messi bids farewell to father who guided his glittering career
-
Hogh's hat-trick inspires Celtic to 5-1 victory over Kilmarnock
-
Raul Fernandez wins British MotoGP Grand Prix
US Supreme Court extends hold on abortion pill restrictions
The US Supreme Court on Wednesday temporarily preserved access to a widely-used abortion pill, delaying its decision on lower court rulings placing restrictions on the drug.
Without commenting on the merits of the case, the nation's highest court extended an administrative stay freezing the lower court decisions until midnight Friday (0400 GMT Saturday).
The initial stay came after the Justice Department filed an emergency appeal asking the court to block the lower court rulings that would have banned or limited use of mifepristone, which accounts for more than half of the abortions in the United States.
That stay had been scheduled to expire at midnight Wednesday and the court, in an order signed by Justice Samuel Alito, opted to extend the hold on the rulings for two more days.
The extension gives the court more time to decide what to do with the divisive case, the most significant on reproductive rights since it tossed out the constitutional right to abortion last year in an opinion penned by Alito, a conservative.
The nine-member panel can rule in any number of ways, and abortion rights and anti-abortion activists -- as well as millions of Americans -- have been on tenterhooks waiting to see how the conservative-dominated court proceeds.
The case stems from a ruling this month by a US District Court judge in Texas that would have banned mifepristone, which was approved for use by the Food and Drug Administration (FDA) in 2000.
An appeals court blocked a ban on the pill, but imposed tough restrictions on access, after which the baton was handed to the Supreme Court.
The Supreme Court, where conservatives wield a 6-3 majority, on Friday temporarily stayed the lower court rulings as it weighs what to do next.
The court could decide to freeze the lower court rulings pending an appeal from the Justice Department and the mifepristone manufacturer Danco Laboratories.
It could also allow the rulings restricting access to the abortion pill to take effect while the case plays out at the appellate level.
The court could also decide to hear arguments in the case itself on an expedited basis.
Complicating the case even further is a ruling by a separate federal court in Washington state that said access to mifepristone should be maintained.
- 'Clear choice' -
Since the Supreme Court overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century, 13 states have banned abortion and it has been severely restricted in others.
Democratic Representative Katherine Clark said Wednesday that the court faces a "clear choice."
"Uphold legal and scientific fact or capitulate to MAGA extremism," Clark said in a reference to former Republican president Donald Trump's "Make America Great Again" slogan.
"This case marks just the latest assault in the MAGA crusade on reproductive freedom," Clark told reporters. "Republicans have one goal -- a nationwide abortion ban."
Opposition to the legal attack on the abortion pill is being spearheaded by the Justice Department, which argued that the initial federal judge's ruling was based on a "deeply misguided assessment" of the pill's safety.
Mifepristone is one component of a two-drug regimen that can be used through the first 10 weeks of pregnancy. It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
The appellate court, while striking down the ban on mifepristone, restricted its use to seven weeks of pregnancy, down from 10, and prohibited distribution by mail.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure -- or ban it outright.
T.Bondarenko--BTB